Cytori IR

631 posts

Cytori IR

Cytori IR

@CytoriIR

Cytori $CYTX is a clinical-stage company focused on bringing autologous adipose-based cell therapies to patients who have significant medical conditions.

San Diego, CA Katılım Eylül 2009
231 Takip Edilen403 Takipçiler
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2lKFyGD Cytori Completes Acquisition of Azaya Therapeutics Assets, Initiates Nanomedicine Program $CYTX
Français
1
0
0
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2kOYmCT Cytori Provides Latest Corporate Update at the 2nd Annual Disruptive Growth & Healthcare Conference $CYTX
English
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2kKAsZK Cytori Receives U.S. Small Business Designation - Substantially Reduces 2017 FDA Filing Fees $CYTX
English
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2jPgp9w Cytori to Acquire Proprietary Nanoparticle Development Platform to Enhance Regenerative Medicine Leadership $CYTX
Română
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2jGlEIN Cytori to Include Lupus Patients in Studies of Cell Therapy for Secondary Raynaud’s Phenomenon $CYTX
English
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2iBDefV Cytori to Expand Scleroderma Focus to Broader Hand Therapy Franchise Under the Habeo™ Cell Therapy Brand $CYTX
English
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2hNU6SC Cytori Announces Common Stock Purchase Agreement with Institutional Investor, Lincoln Park Capital Fund, LLC $CYTX
English
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2hNYCAw Ronald Martell to Join Cytori Therapeutics’ Board of Directors $CYTX
English
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2hmwPY6 Cytori Pivotal ADRESU Incontinence Trial Hits 50% Enrollment Milestone $CYTX
Română
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
Sustained Clinical Benefit After 3 Year Follow Up in Scleroderma Trial buff.ly/2gV4JAG $CYTX
English
0
1
1
0
Cytori IR
Cytori IR@CytoriIR·
buff.ly/2g2cgg4 Cytori Announces Two Year Follow-Up Published on EU Scleroderma Trial $CYTX
English
1
0
0
0
Cytori IR
Cytori IR@CytoriIR·
ABEONA THERAPEUTICS ANNOUNCES DATA SAFETY MONITORING BOARD APPROVES ABO-102 DOSE ESCALATION buff.ly/2dKkqNV
English
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
CYTX licensee, Kerastem, completes US Phase II enrollment in STYLE clinical trial buff.ly/2cSwcWC $CYTX
English
0
0
0
0
Cytori IR
Cytori IR@CytoriIR·
BARDA Increases Contract Option with Cytori to Advance Countermeasure Clinical Trial - See more at: buff.ly/2ddYitT
English
0
0
0
0

Keşfet

@elonmusk @BarackObama @taylorswift13 @cristiano @BillGates @NASA @nikifrancismediavine @katyperry